About Proscribe
Proscribe is a Real Estate & Construction company based in North Ryde (Australia) founded in 2000, and was acquired by Envision Pharma Group in February 2014. Property valuation and conveyancing services are provided by Proscribe. It operates on a Professional Services model. Its chief executive, as recorded, is David Thompson. Proscribe offers products and services including Property Valuation and Conveyancing. Its focus areas include Real Estate, Property Services and Valuation and Conveyancing.
Company details
Property valuation and conveyancing services are delivered by Proscribe to assist clients in real estate transactions. Focus is placed on accurate property pricing and legal support for property transfers across various Australian regions like Brisbane, Sydney, and Perth. Solutions are tailored to meet the needs of buyers, sellers, and investors in the real estate sector.
- Headquarters North Ryde, Australia
- Stage Acquired
- SectorsReal Estate & Construction
- Website proscribe.com.au
- Social LinkedIn
- Acquired by Envision Pharma Group (Feb 2014)
- Investors
- Acquired byEnvision Pharma Group
(Feb 2014)
Products & Services of Proscribe
Proscribe offers a comprehensive portfolio of products and services, including Property Valuation and Conveyancing.
Property valuation services are provided for accurate pricing.
Conveyancing services are offered for property transaction support.
Investors in Proscribe
Proscribe has secured backing from 1 investor. Prominent investors backing the company include Envision Pharma Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Compliant global publication planning is offered for life sciences. | 2001 | envisionpharmagroup.com | Fairfield, United States |
Investor details for Proscribe
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Proscribe
1 people are tracked at Proscribe (1 in leadership).
| Name | Role | Group |
|---|---|---|
David Thompson | CEO | Leadership |
Complete people profiles for Proscribe
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Proscribe
2 dated milestones of Proscribe across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Proscribe is founded.
- Exit Acquired by Envision Pharma Group.
Web traffic of Proscribe
The website of Proscribe (proscribe.com.au) receives about 1.5K visits a month.
- Monthly visits1.5K
▲ 304.9% vs previous month
Websites whose visitors overlap most with Proscribe. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
medsense.co.uk | medsense.co.uk | 100% | – | ||
panafarma.se | panafarma.se | 62% | – | ||
| parcelproperty.com.au | 38% | #2,016,803 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Proscribe
Proscribe was founded in 2000.
Proscribe is headquartered in North Ryde, Australia. It is registered at North Ryde, New South Wales, Australia.
David Thompson is the CEO of Proscribe, as recorded in our data.
Property valuation and conveyancing services are delivered by Proscribe to assist clients in real estate transactions. Focus is placed on accurate property pricing and legal support for property transfers across various Australian regions like Brisbane, Sydney, and Perth. Solutions are tailored to meet the needs of buyers, sellers, and investors in the real estate sector.
Proscribe offers Property Valuation and Conveyancing.
Proscribe has 1 investor. Key investors include Envision Pharma Group.
Yes. Proscribe was acquired by Envision Pharma Group in February 2014.